Panthipa Laowansiri in Lady Lake, Florida

Home Florida Lady Lake

Panthipa Laowansiri has Infectious Disease as her primary medical specialty. Their primary office is: 929 N Hwy 441 in Lady Lake, Florida.

They're a part of the: Florida Health Care Llc medical group which has around 3 members. You can call their office at 352-350-2474 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2004 (around 20 years of experience). They are listed as doing telehealth appointments.

Panthipa Laowansiri Office Phone and Directions

Panthipa Laowansiri
Florida Health Care Llc
929 N Hwy 441
Lady Lake, Florida 32159
352-350-2474

Patient Ratings
Please rate your experience with Panthipa Laowansiri below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 352-350-2474

Enter a starting address:

Healthcare Info for Panthipa Laowansiri

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2004
The Primary Medical Specialty for Panthipa Laowansiri is listed as: Infectious Disease
Approximate Years of Experience: 20
PAC (PECOS ID)#: 6709041056
NPI #: 1801057724
NPI Created On: 06/23/2008
NPI Last Updated Listed as: 11/12/2015
Primary Taxonomy Code: 207R00000X
License Number:
125052304
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Thai, English.

Services and Procedures include:

Removal of skin and tissue first 20 sq cm or less
Removal of skin and tissue
Removal of tissue from wounds per session
Management and supervision of oxygen chamber therapy per session
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Hospital observation care, typically 70 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp
Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 842112473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: WOUND CARE

Name of Drug #1: HYDROFERA BLUE

Payments Total: $23

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 835463911

Being Disputed:: No

Product Related: Yes

Drug or Biological: Medical Supply

Product Category #1: Wound Care

Name of Drug #1: Puraply Antimicrobial

Payments Total: $25

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 835463913

Being Disputed:: No

Product Related: Yes

Drug or Biological: Medical Supply

Product Category #1: Wound Care

Name of Drug #1: Puraply Antimicrobial

Payments Total: $29

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 835463915

Being Disputed:: No

Product Related: Yes

Drug or Biological: Medical Supply

Product Category #1: Wound Care

Name of Drug #1: Puraply Antimicrobial

Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 835463917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Medical Supply

Product Category #1: Wound Care

Name of Drug #1: Puraply

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 835463919

Being Disputed:: No

Product Related: Yes

Drug or Biological: Medical Supply

Product Category #1: Wound Care

Name of Drug #1: Puraply

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2745759;CONCUR;10774524

Record ID:: 848226267

Being Disputed:: No

Product Related: Yes

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2775887;CONCUR;10774524

Record ID:: 848226269

Being Disputed:: No

Product Related: Yes

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Marketed Product is a Biological without a NDC code which caused it to fail validation; therefore, it is submitted as a Medical Supply as a workaround to ensure completeness of data submission.

Record ID:: 843070419

Being Disputed:: No

Product Related: Yes

Drug or Biological: Medical Supply

Product Category #1: Other Advanced Wound Management

Name of Drug #1: GRAFIX PL

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 843129231

Being Disputed:: No